Page last updated: 2024-11-02

pioglitazone and Escherichia coli Infections

pioglitazone has been researched along with Escherichia coli Infections in 2 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Miyazaki, H1
Kinoshita, M2
Nakashima, H2
Nakamura, S1
Saitoh, D1
Nakashima, M1
Kotani, A1
Ishikiriyama, T1
Kato, S1
Hiroi, S1
Seki, S1

Other Studies

2 other studies available for pioglitazone and Escherichia coli Infections

ArticleYear
Pioglitazone Modifies Kupffer Cell Function and Protects against
    International journal of molecular sciences, 2022, Oct-22, Volume: 23, Issue:21

    Topics: Animals; Bacteremia; Escherichia coli; Escherichia coli Infections; Hypoglycemic Agents; Kupffer Cel

2022
Pioglitazone improves phagocytic activity of liver recruited macrophages in elderly mice possibly by promoting glucose catabolism.
    Innate immunity, 2019, Volume: 25, Issue:6

    Topics: Aging; Animals; CD11b Antigen; Cytokines; Escherichia coli; Escherichia coli Infections; Glucose; In

2019